Q2 2021

Filed Aug 17, 2021 · 10-Q · 48 days after period end · 0001193125-21-249118

Q2 2021 · 10-Q

Revenue

$34.75M

no prior Q2 2020 on file

Net Income

$13.24M

no prior Q2 2020 on file

EPS, diluted—

Operating Income$10,260,000—

Operating Cash Flowderived$17,944,996—

Same quarter

no prior Q2 2020 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2021 · filed Aug 17, 2021 · 48 d after period end

biote Corp. · CIK 1819253 · Engraved from SEC EDGAR